Back to today’s briefing

Story perspectives

Revolutionary Fridge-Free Vaccine Set to Transform Global Access

4/29/2025

48 11

Summary

Story summary

British scientists are pioneering a groundbreaking clinical trial for a revolutionary fridge-free vaccine, SPVX02, designed to tackle vaccine wastage in developing countries. This innovative tetanus-diphtheria vaccine can be stored at room temperature for up to 18 months. With hopes for global availability by 2027, this could reshape vaccine distribution and accessibility worldwide.

1 of 1

Story summary

British scientists are pioneering a groundbreaking clinical trial for a revolutionary fridge-free vaccine, SPVX02, designed to tackle vaccine wastage in developing countries. This innovative tetanus-diphtheria vaccine can be stored at room temperature for up to 18 months. With hopes for global availability by 2027, this could reshape vaccine distribution and accessibility worldwide.